首页> 外文会议>International Molecular Medicine Tri-Conference. >Detecting Rare Mutations in Cell-Free DNA by Integrating an Ultrafast Amplicon-Based Targeted Library Preparation Method with Double-Stranded Unique Molecular Identifiers
【24h】

Detecting Rare Mutations in Cell-Free DNA by Integrating an Ultrafast Amplicon-Based Targeted Library Preparation Method with Double-Stranded Unique Molecular Identifiers

机译:通过与双链独特的分子标识符集成超速率扩增子靶向文库制备方法,通过与双链独特的分子标识符进行整合来检测无细胞DNA的罕见突变

获取原文

摘要

The use of as cell-free DNA (cfDNA) for testing has seen tremendous growth in recent years, as liquid biopsy is a noninvasive and easily obtainable sample type with many diagnostics and prognostic values. Liquid biopsy can enable new applications, but it also presents challenges toward accurate variant detection due to the low fraction of mutant DNA present in theses samples, which can be easily buried by the artifacts and background noise from systematic PCR and sequencing errors, leading to false negative results. While some progress has been made by ligating adapters with unique molecular identifiers (UMIs) in hybrid capture-based methods followed by deep sequencing, such approaches have time-consuming, complicated, and tedious workflows, often resulting in disappointingly low on-target rates. Additionally, the large amount of cfDNA required for hybrid capture workflows is not realistic to obtain from patients.
机译:近年来,使用作为无细胞DNA(CFDNA)进行测试的巨大增长,因为液体活组织检查是一种非侵入性且易于获得的样品类型,具有许多诊断和预后值。液体活组织检查可以实现新的应用,但它也提出了朝着这些样品中存在的低突变体DNA的突变体DNA的精确变体检测挑战,这可以容易地被系统PCR和测序误差从伪影和背景噪声掩埋,导致假消极结果。虽然通过在基于混合捕获的方法中具有独特的分子标识符(UMIS)的综合分子标识符(UMIS)进行了一些进展,但是深度测序,这种方法具有耗时,复杂和繁琐的工作流程,通常导致令人失望的低目标率。另外,杂交捕获工作流程所需的大量CFDNA不适用于从患者获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号